Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women may have causes other than hormones.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Topical eflornithine helps maintain hair reduction after IPL therapy in women with facial hirsutism.

The perception of excessive hair growth in women as abnormal is more influenced by cultural norms than by medical reasons.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Acne is an important sign of androgen excess disorders in women.

Men's thigh hair grows longer and has a longer growth cycle than women's, but arm hair growth is similar between genders.

Fear of hair-related issues causes significant mental distress, especially in high-stress women.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Spironolactone is effective for treating acne, hirsutism, and androgenic alopecia in women with few side effects.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Eflornithine cream effectively reduces facial hair in women with hirsutism.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

About one-third of Saudi women with female pattern hair loss also have thinning hair at the back of their head.

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.